Correlating Receptor Status with Nottingham Prognostic Index in Breast Cancer

被引：0
作者：
Gupta, Rohan [1 ]
Khanna, Rahul [1 ]
Kar, Amrita G. [2 ]
Khanna, Seema [1 ]
Khanna, Siddharth [3 ]
Meena, Ram Niwas [1 ]
机构：
[1] Banaras Hindu Univ, Inst Med Sci, Dept Surg, Varanasi 221005, India
[2] Banaras Hindu Univ, Inst Med Sci, Dept Pathol, Varanasi 221005, India
[3] Aligarh Muslim Univ, Dept Ophthalmol, Aligarh 202002, India
来源：
INDIAN JOURNAL OF SURGERY | 2024年 / 86卷 / 02期
关键词：
Breast cancer; Nottingham Prognostic Index; Receptor status;
D O I：
10.1007/s12262-023-03865-2
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The biological behavior and prognosis of breast cancer is often unpredictable with a number of factors contributing to the outcome. Nottingham's Prognostic Factor (NPI) takes into account the tumor size, nodal status, and histological grade of tumor. The receptor status considers the hormone receptor and HER2 status. The aim of the study was to correlate the NPI score with the receptor status expression in Indian women with breast cancer. A total of 78 breast cancer patients who underwent upfront modified radical mastectomy were recruited. NPI score and receptor status assessment was done at histopathological examination of the specimen. Hormone receptor negative breast cancer tended to have a higher NPI score compared to hormone receptor positive patients. However, this difference did not achieve statistical significance. NPI score parameters except for the histological grade are a reflection of the duration or time span of the tumor. On the contrary, the receptor status is indicative of the tumor biology and not of its time duration. A scoring system which incorporates the three parameters of the NPI as well as the receptor status would be the best prognostic index as well as predictive regarding the choice of adjuvant therapy.
引用
收藏
页码：344 / 347
页数：4
相关论文
共 8 条
[1]   THE NOTTINGHAM-PROGNOSTIC-INDEX APPLIED TO 9,149 PATIENTS FROM THE STUDIES OF THE DANISH-BREAST-CANCER-COOPERATIVE-GROUP (DBCG) [J].
BALSLEV, I ;
AXELSSON, CK ;
ZEDELER, K ;
RASMUSSEN, BB ;
CARSTENSEN, B ;
MOURIDSEN, HT .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (03) :281-290
[2]   Comparative evaluation of the modified Scarff-Bloom-Richardson grading system on breast carcinoma aspirates and histopathology [J].
Bansal, Cherry ;
Singh, U. S. ;
Misra, Sanjeev ;
Sharma, Kiran Lata ;
Tiwari, Vandana ;
Srivastava, A. N. .
CYTOJOURNAL, 2012, 9
[3]   The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone [J].
Campbell, Esther J. ;
Tesson, Mathias ;
Doogan, Flora ;
Mohammed, Zahra M. A. ;
Mallon, Elizabeth ;
Edwards, Joanne .
BRITISH JOURNAL OF CANCER, 2016, 115 (08) :967-973
[4]   The prognostic contribution of estrogen and progesterone receptor status to a modified version of the Nottingham Prognostic Index [J].
Collett, K ;
Skjærven, R ;
Mæhle, BO .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 48 (01) :1-9
[5]   THE NOTTINGHAM PROGNOSTIC INDEX IN PRIMARY BREAST-CANCER [J].
GALEA, MH ;
BLAMEY, RW ;
ELSTON, CE ;
ELLIS, IO .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (03) :207-219
[6]   The Nottingham prognostic index for invasive carcinoma of the breast [J].
Lee, Andrew H. S. ;
Ellis, Ian O. .
PATHOLOGY & ONCOLOGY RESEARCH, 2008, 14 (02) :113-115
[7]   Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer [J].
Li, Xiaoxian ;
Yang, Jing ;
Peng, Limin ;
Sahin, Aysegul A. ;
Huo, Lei ;
Ward, Kevin C. ;
O'Regan, Ruth ;
Torres, Mylin A. ;
Meisel, Jane L. .
BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) :279-287
[8]   Correlation analysis between molecular subtypes and Nottingham Prognostic Index in breast cancer [J].
Zhen, Hongchao ;
Yang, Liuting ;
Li, Li ;
Yu, Junxian ;
Zhao, Lei ;
Li, Yingying ;
Li, Qin .
ONCOTARGET, 2017, 8 (43) :74096-74105
1